Jie Tong
- Molecular Biology top 10%
- Biomedical Engineering
- Immunology top 10%
- Oncology
- Epidemiology
- Topics
- Ferroptosis and cancer prognosis (5 papers)Hematopoietic Stem Cell Transplantation (5 papers)Cellular Mechanics and Interactions (4 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Jie Tong
77 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Molecular Biology 734
- Biomedical Engineering 236
- Immunology 219
- Oncology 215
- Epidemiology 213
Countries citing papers authored by Jie Tong
This map shows the geographic impact of Jie Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Tong more than expected).
Fields of papers citing papers by Jie Tong
This network shows the impact of papers produced by Jie Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Tong. The network helps show where Jie Tong may publish in the future.
Co-authorship network of co-authors of Jie Tong
This figure shows the co-authorship network connecting the top 25 collaborators of Jie Tong. A scholar is included among the top collaborators of Jie Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Tong. Jie Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | 27 | |
| 3 | 4 | |
| 4 | 3 | |
| 5 | 25 | |
| 6 | 2 | |
| 7 | 4 | |
| 8 | 23 | |
| 9 | 12 | |
| 10 | 14 | |
| 11 | 9 | |
| 12 | 32 | |
| 13 | 66 | |
| 14 | 1 | |
| 15 | 6 | |
| 16 | 2 | |
| 17 | 125 | |
| 18 | 41 | |
| 19 | 11 | |
| 20 | [Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions]. | 4 |
About Jie Tong
Jie Tong is a scholar working on Conservation, Hematology and Cancer Research, having authored 80 papers that have together received 1.8k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (5 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Cellular Mechanics and Interactions (4 papers). The work is most often cited by research in Cancer Research (198 citations), Geriatrics and Gerontology (46 citations) and Hematology (126 citations). Jie Tong has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Dongjie Li, Fu‐Ming Shen, Pei Wang, Fei Wang, Chang Su, Weiqiang Chen, Jianbao Zhang, Weiyi Qian, Hui Fu and Peng Cui. Their work appears in journals such as Nature Communications, Blood and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.